Key facts
- This page summarizes Robert E. George's Form 4 filing for Moleculin Biotech, Inc. (MBRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 27 Dec 2023, 07:31.
Robert E. George - 26 Dec 2023 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)
- Role
- Director
- Signature
- /s/ Jonathan P. Foster by Power of Attorney
- Issuer symbol
- MBRX
- Transactions as of
- 26 Dec 2023
- Net transaction value
- +$10,000
- Form type
- 4
- Filing time
- 27 Dec 2023, 07:31:57 UTC
- Previous filing
- 26 May 2023
- Next filing
- 06 Nov 2024
- SEC filing
- View on sec.gov
Reporting owner
2 facts
Issuer context
1 fact
Transaction snapshot
2 facts
SEC evidence
5 facts
Key filing fact
Robert E. George filed Form 4 for Moleculin Biotech, Inc. (MBRX) on 27 Dec 2023.
Change
- Previous filing in this sequence was filed on 26 May 2023.
- Current net transaction value: +$10,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported transactions
MBRX
transaction
Common Stock
Purchase
- Transaction value
- $10,000
- Shares
- +14,493
- Change %
- +8678%
- Price
- $0.6900
- Shares after
- 14,660
- Date
- 26 Dec 2023
- Ownership
- Direct
* indicates a reported price that failed the local validity check.